GlycoMimetics files 8-K with slide presentation for investor meetings; content not disclosed

CRESCENT BIOPHARMA, INC.

Slide presentation furnished as Exhibit 99.1 for investor meetings on October 4, 2022.
No financial or clinical data from the presentation is included in this filing.
The presentation is provided under Regulation FD and is not deemed filed for SEC purposes.

item 7.01 item 9.01

CRESCENT BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001558370-22-014828

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.